Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 198 participants.
Also called NCT04814121
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 198 participants
- Registry
-
NCT04814121
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Unknown status
Technical summary
Registry record NCT04814121. Randomized; quadruple masking; primary purpose treatment. Start 2021-05-01 (anticipated); primary completion 2023-09-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Suxiao Jiuxin Pills in Microvascular Obstruction in Patients With Acute Coronary Syndrome
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Suxiao Jiuxin Pills
- Intervention (Drug)
- The placebo of Suxiao Jiuxin Pills
- Lead sponsor
- Guangzhou University of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct04814121- Content hash
5b32a849ed7cc0ddb04542d1676fef79ee8eb8a588dbb5246073167a3c4292f5